secwatch / observer

8-K filed May 5, 2025, 7:59 PM ET ticker RXRX CIK 0001601830

earnings confidence high sentiment negative materiality 0.75

Recursion Q1 net loss widens to $202.5M; Sanofi milestone $7M; pipeline refocused

RECURSION PHARMACEUTICALS, INC.

2025-Q1 EPS reported -$0.50 revenue$14,745,000

Q1 net loss $202.5M vs $91.4M YoY; revenue $15M (up from $14M).
Cash & equivalents $509M; projected cash runway into mid-2027; 2025 cash burn ≤$450M.
Achieved 4th Sanofi milestone, $7M payment; total Sanofi cash inflow $130M to date.
Deprioritized 3 clinical programs (REC-2282, REC-994, REC-3964) to focus on oncology and rare disease.
REC-4881 preliminary data: median 43% polyp burden reduction in FAP Phase 1b/2 study.

item 2.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001601830-25-000074
form_type: 8-K
ticker: RXRX
cik: 0001601830
company_name: RECURSION PHARMACEUTICALS, INC.
filed_at: 2025-05-05T23:59:59+00:00
discovered_at: 2026-05-14T18:02:48.970826+00:00
generated_at: 2026-05-22T17:25:47.516395+00:00
sec_items: ["2.02", "7.01", "9.01"]
event_type: earnings
sentiment: negative
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001601830-25-000074
json_url: https://secwatch.observer/filing/0001601830-25-000074.json
markdown_url: https://secwatch.observer/filing/0001601830-25-000074.md
text_url: https://secwatch.observer/filing/0001601830-25-000074.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000074/0001601830-25-000074-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183025000074/rxrx-20250505.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

FNGR

FingerMotion FY2026 revenue down 32% to $24.1M; net loss widens to $7.0M

FingerMotion, Inc. May 29, 2026, 5:12 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

ADSK

Autodesk Q1 FY27 revenue up 18% to $1.93B, GAAP EPS $2.32; acquires MaintainX

Autodesk, Inc. May 28, 2026, 4:14 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

OKTA

Okta Q1 FY2027 rev $765M (+11% YoY); GAAP net income $74M; free cash flow $271M

Okta, Inc. May 28, 2026, 4:03 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SOTK

Sono-Tek reports FY2026 net income up 42% to $1.8M; gross margin expands to 51%

SONO TEK CORP May 28, 2026, 7:10 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

DLTR

Dollar Tree Q1 net sales +7.2%, comp +3.5%, adj EPS $1.74 (+38%), raises FY guidance

DOLLAR TREE, INC. May 28, 2026, 6:31 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

BBWI

BBWI Q1 sales down 3%, adjusted EPS $0.32 beats guidance; CFO Boratto to step down June 12

Bath & Body Works, Inc. May 27, 2026, 7:12 AM ET earnings Items 2.02, 7.01, 5.02, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

SMTC

Semtech reports record Q1 net sales $291M, GAAP EPS $0.27, adjusted EPS $0.51

SEMTECH CORP May 26, 2026, 4:07 PM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

EMAT

EMAT reports Q1 GAAP net loss of $440.3M on $425M non-cash charge; adjusted loss $15.1M

Evolution Metals & Technologies Corp. May 22, 2026, 9:28 AM ET earnings Items 2.02, 7.01, 9.01

same SEC item: 2.02, 7.01, 9.01 same event type: earnings similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001601830-25-000074

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.